Pyridostigmine in the Treatment of Orthostatic Hypotension

Overview

Journal Clin Auton Res

Date 2005 Dec 20

PMID 16362550

Citations 2

Authors

Jean-Michel Senard

Affiliations

Soon will be listed here.

Citing Articles

The recommendations of a consensus panel for the screening, diagnosis, and treatment of neurogenic orthostatic hypotension and associated supine hypertension.

Gibbons C, Schmidt P, Biaggioni I, Frazier-Mills C, Freeman R, Isaacson S J Neurol. 2017; 264(8):1567-1582.

PMID: 28050656 PMC: 5533816. DOI: 10.1007/s00415-016-8375-x.

Acetylcholinesterase inhibition and orthostatic hypotension.

Provitera V, Nolano M, Pagano A Clin Auton Res. 2006; 16(2):136.

PMID: 16572351 DOI: 10.1007/s10286-006-0336-5.

References

Rowsey P, Yang Y, Gordon C . Peripheral cholinergic pathway modulates hyperthermia induced by stress in rats exposed to open-field stress. J Appl Physiol (1985). 2002; 92(2):789-94. DOI: 10.1152/japplphysiol.00240.2001. View

Li L, Gunasekar P, Borowitz J, Isom G . Muscarinic receptor-mediated pyridostigmine-induced neuronal apoptosis. Neurotoxicology. 2000; 21(4):541-52. View

Wacks I, Oster J, Perez G, Kett D . Spurious hyperchloremia and hyperbicarbonatemia in a patient receiving pyridostigmine bromide therapy for myasthenia gravis. Am J Kidney Dis. 1990; 16(1):76-9. DOI: 10.1016/s0272-6386(12)80790-6. View

Peden-Adams M, Dudley A, EuDaly J, Allen C, Gilkeson G, Keil D . Pyridostigmine bromide (PYR) alters immune function in B6C3F1 mice. Immunopharmacol Immunotoxicol. 2004; 26(1):1-15. DOI: 10.1081/iph-120029939. View

Kelsall H, Sim M, Forbes A, Glass D, McKenzie D, Ikin J . Symptoms and medical conditions in Australian veterans of the 1991 Gulf War: relation to immunisations and other Gulf War exposures. Occup Environ Med. 2004; 61(12):1006-13. PMC: 1740679. DOI: 10.1136/oem.2003.009258. View

Park K, Long J, Cannon J . Reversal of antihypertensive agent-induced postural hypotension with physostigmine. Arch Int Pharmacodyn Ther. 1991; 311:155-65. View

Douchet M, QUIRING E, Bronner F, Messier M, Chauvin M, Warter J . [Paradoxal lowering of parasympathetic indices in myasthenic patients]. Arch Mal Coeur Vaiss. 1999; 92(6):711-7. View

Iwasaki Y, Wakata N, Kinoshita M . Parkinsonism induced by pyridostigmine. Acta Neurol Scand. 1988; 78(3):236. DOI: 10.1111/j.1600-0404.1988.tb03653.x. View

Nobrega A, dos Reis A, Moraes R, Bastos B, Ferlin E, Ribeiro J . Enhancement of heart rate variability by cholinergic stimulation with pyridostigmine in healthy subjects. Clin Auton Res. 2001; 11(1):11-7. DOI: 10.1007/BF02317797. View

10.

Castro R, Porphirio G, Serra S, Nobrega A . Cholinergic stimulation with pyridostigmine reduces the QTc interval in coronary artery disease. Braz J Med Biol Res. 2002; 35(6):685-9. DOI: 10.1590/s0100-879x2002000600008. View

11.

Levin N, Karussis D, Abramsky O . Parkinson's disease associated with myasthenia gravis. A report of 4 cases. J Neurol. 2003; 250(6):766-7. DOI: 10.1007/s00415-003-1088-y. View

12.

Lazartigues E, Freslon J, Tellioglu T, Brefel-Courbon C, Pelat M, Tran M . Pressor and bradycardic effects of tacrine and other acetylcholinesterase inhibitors in the rat. Eur J Pharmacol. 1998; 361(1):61-71. DOI: 10.1016/s0014-2999(98)00717-1. View

13.

Serra S, Costa R, Bastos B, Bousquet Santos K, Ramalho S, da Nobrega A . Exercise stress testing in healthy subjects during cholinergic stimulation after a single dose of pyridostigmine. Arq Bras Cardiol. 2001; 76(4):279-84. DOI: 10.1590/s0066-782x2001000400002. View

14.

Sandroni P, Opfer-Gehrking T, Singer W, Low P . Pyridostigmine for treatment of neurogenic orthostatic hypotension [correction of hypertension]--a follow-up survey study. Clin Auton Res. 2005; 15(1):51-3. DOI: 10.1007/s10286-005-0225-3. View

15.

Singer W, Opfer-Gehrking T, McPhee B, Hilz M, Bharucha A, Low P . Acetylcholinesterase inhibition: a novel approach in the treatment of neurogenic orthostatic hypotension. J Neurol Neurosurg Psychiatry. 2003; 74(9):1294-8. PMC: 1738643. DOI: 10.1136/jnnp.74.9.1294. View

16.

Schumm W, Reppert E, Jurich A, Bollman S, Webb F, Castelo C . Pyridostigmine bromide and the long-term subjective health status of a sample of over 700 male Reserve Component Gulf War era veterans. Psychol Rep. 2002; 90(3 Pt 1):707-21. DOI: 10.2466/pr0.2002.90.3.707. View

17.

Cook M, Graham C, Sastre A, Gerkovich M . Physiological and performance effects of pyridostigmine bromide in healthy volunteers: a dose-response study. Psychopharmacology (Berl). 2002; 162(2):186-92. DOI: 10.1007/s00213-002-1074-6. View